ANI Pharmaceuticals Profile

USD 1.05  1.5%

Payment of 1364 shares by Charlotte Arnold of ANI Pharmaceuticals subject to Rule 16b-3

ANI Pharmaceuticals Inc insider trading alert for payment of common stock par value $0.0001 by Charlotte Arnold, Chief Financial Officer, on January 16, 2018. This event was filed by Ani Pharmaceuticals Inc with SEC on 2014-02-07. Statement of changes in beneficial ownership - SEC Form 4 [view details]   

ANI Pharmaceuticals Summary

ANI Pharmaceuticals Inc (ANIP) is traded on NASDAQ General Markets in USA. It is located in MINNESOTA, U.S.A and employs 108 people. ANI Pharmaceuticals is listed under Pharmaceutical Products category by Fama And French industry classification.The company currently falls under 'Small-Cap' category with current market capitalization of 814.31 M. ANI Pharmaceuticals Inc conducts business under Healthcare sector and is part of Biotechnology industry. This company has 11.64 M outstanding shares of which 882.69 K shares are presently shorted by private and institutional investors with about 6.07 trading days to cover. ANI Pharmaceutica currently holds about 18.03 M in cash with 35.7 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.55.
Check ANI Pharmaceuticals Probability Of Bankruptcy

Ownership Allocation (%)

Top Holders

Major Institutional Holders

InstituionSecurity TypeTotal SharesValue
Schwab Charles Investment Management IncCommon Shares64.7 K4.2 M
Thomson Horstmann Bryant IncCommon Shares20.1 K1.3 M
Simplex Trading LlcCall Options30.035 K
Cutler Group LpPut Options3.5 K1000
Mangrove PartnersDebt18.8 K20.3 M
View ANI Pharmaceuticals Diagnostics

Selected ANI Pharmaceuticals Inc Income Statement Over Time

Consolidated Income    Earning Before Interest and Taxes EBIT    Net Income    

Key Fundamentals

ANI Pharmaceuticals Against Markets